Dianthus Therapeutics | MGTA - Stock


Dianthus Therapeutics reported 384K in Stock for its fiscal quarter ending in September of 2025.





Stock Change Date
Akebia Therapeutics USD 15.61M 3.03M Dec/2025
Avita Medical AUD 6.93M 614K Dec/2025
Celltrion KRW 2.71T 121.94B Jun/2025
Cspc Pharmaceutical CNY 2.87B 259.23M Jun/2025
Divis Laboratories Ltd INR 32.36B 910M Mar/2025
Kangmei Pharma CNY 2.45B 12.27M Sep/2025
Knight Therapeutics CAD 95.4M 2.91M Mar/2024
Laboratorios Farma EUR 327.67M 2.28M Jun/2025
Medical Developments International AUD 9.45M 679K Jun/2025
Moderna USD 332M 92M Sep/2025
Organigram Holdings CAD 132.71M 8.76M Dec/2025
Organon & Co USD 1.49B 34M Sep/2025
Pharma Mar EUR 50.64M 1.13M Dec/2025
Qiagen NV USD 290.23M 2.32M Sep/2025
Revvity USD 379.5M 420K Dec/2025
Sartorius EUR 827.9M 30.5M Sep/2025
Sino Biopharmaceutical CNY 1.84B 156.17M Jun/2024
Tilray USD 282.79M 11.9M Jun/2025
Viatris USD 4B 112.2M Dec/2025
Xeris Pharmaceuticals USD 68.67M 1.21M Dec/2025
Zealand Pharma A/S 10.7M 9.9M Dec/2024
Zz Pientze Pharmaceu CNY 5.72B 778.27M Jun/2025